Literature DB >> 15672342

Life-threatening presentation of mediastinal neoplasms: report on 7 consecutive pediatric patients.

Marco Piastra1, Antonio Ruggiero, Elena Caresta, Antonio Chiaretti, Silvia Pulitano, Giancarlo Polidori, Riccardo Riccardi.   

Abstract

BACKGROUND: Cases of respiratory failure at presentation in children with anterior mediastinal malignancies can be very challenging for clinicians. Seven consecutive children presenting with superior mediastinal syndrome are reported needing urgent critical care approach. PATIENTS AND METHODS: Seven children (age range from 0.8 to 14 years; mean, 4.5 years) suffered from critical mediastinal neoplasms. Clinical presentation, laboratory findings, treatment, and outcome are discussed.
SETTING: a tertiary-care 6-bed medical and surgical pediatric intensive care in a university hospital. Interventions included emergency management, resuscitation and intensive care admission, and diagnostic and therapeutic procedures.
RESULTS: All cases showed a respiratory compromise and underwent ventilatory and/or cardiovascular support. Two patients needed renal replacement therapy. Pediatric Intensive Care Unit discharge was achieved in all patients.
CONCLUSIONS: Critical or extreme presentation of mediastinal neoplasms does not preclude a good clinical outcome: an intensive care approach is essential to allow patient recovery and effective antineoplastic therapy administration.

Entities:  

Mesh:

Year:  2005        PMID: 15672342     DOI: 10.1016/j.ajem.2003.12.025

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  Superior vena cava syndrome in children.

Authors:  Vineeta Gupta; Srikanth R Ambati; P Pant; Baldev Bhatia
Journal:  Indian J Hematol Blood Transfus       Date:  2008-05-01       Impact factor: 0.900

2.  A Pitfall of Wheezing - A Large Mediastinal Mass Presenting as Persistent Wheezing: A Case Report.

Authors:  Kenji Iwai; Kenichi Tetsuhara; Satoshi Tsuji; Mitsuru Kubota
Journal:  Cureus       Date:  2022-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.